Noevir Holdings Co., Ltd. Stock price

Equities

4928

JP3760450001

Personal Products

Delayed Japan Exchange 09:17:50 2024-03-28 pm EDT 5-day change 1st Jan Change
5,220 JPY +0.58% Intraday chart for Noevir Holdings Co., Ltd. -0.38% +1.56%
Sales 2024 * 63.4B 419M Sales 2025 * 65.15B 430M Capitalization 177B 1.17B
Net income 2024 * 7.9B 52.18M Net income 2025 * 8.15B 53.83M EV / Sales 2024 * 2.8 x
Net cash position 2024 * - 0 Net cash position 2025 * - 0 EV / Sales 2025 * 2.72 x
P/E ratio 2024 *
22.4 x
P/E ratio 2025 *
21.8 x
Employees 1,368
Yield 2024 *
4.34%
Yield 2025 *
4.43%
Free-Float 47.64%
More Fundamentals * Assessed data
Dynamic Chart
Noevir Holdings Co., Ltd. Provides Dividend Guidance for the Fiscal Year Ending September 30, 2024 CI
Noevir Holdings Co., Ltd. Announces Dividend for the Fiscal Year Ended September 30, 2023, Payable on December 11, 2023 CI
Noevir Holdings Co., Ltd. Provides Consolidated Earnings Guidance for the Fiscal Year Ending September 30, 2024 CI
Noevir Holdings Co., Ltd. Provides Dividend Guidance for the Fiscal Year Ending September 30, 2023 CI
Noevir Holdings Co., Ltd. Provides Consolidated Earnings Guidance for the Fiscal Year Ending September 30, 2024 CI
Noevir Holdings Co., Ltd. Reports Earnings Results for the Half Year Ended March 31, 2023 CI
Noevir Holdings Co., Ltd. Provides Year-End Dividend Guidance for the Fiscal Year Ending September 30, 2023 CI
Noevir Holdings Co., Ltd. Provides Consolidated Earnings Guidance for the Fiscal Year Ending September 30, 2023 CI
Noevir Holdings Co., Ltd. Provides Year-End Dividend Guidance for the Fiscal Year Ending September 30, 2023 CI
Noevir Holdings Co., Ltd. Provides Consolidated Earnings Guidance for the Six Months Ending March 2023 and for the Fiscal Year Ending September 30, 2023 CI
Noevir Holdings Co., Ltd. Provides Consolidated Earnings Guidance for the Six Months Ending March 2023 and for the Fiscal Year Ending September 30, 2023 CI
Noevir Holdings Co., Ltd. Provides Year-End Dividend Guidance for the Fiscal Year Ending September 30, 2023 CI
Noevir Holdings Co., Ltd. Announces Year-End Dividend for the Fiscal Year Ended September 30, 2022, Payable on December 09, 2022 CI
Noevir Holdings Co., Ltd. Provides Consolidated Earnings Guidance for the Period Ending September 2022 CI
Noevir Holdings Co., Ltd. Provides Dividend Guidance for the Year Ending September 30, 2022 CI
More news
1 day+0.58%
1 week-0.38%
3 months+1.56%
6 months-1.32%
Current year+1.56%
More quotes
1 week
5 180.00
Extreme 5180
5 290.00
1 month
5 080.00
Extreme 5080
5 290.00
Current year
5 080.00
Extreme 5080
5 320.00
1 year
4 985.00
Extreme 4985
5 770.00
3 years
4 700.00
Extreme 4700
6 140.00
5 years
3 985.00
Extreme 3985
6 330.00
10 years
1 837.00
Extreme 1837
9 170.00
More quotes
Managers TitleAgeSince
President 68 11-03-21
Chief Tech/Sci/R&D Officer - -
Director/Board Member - Nov. 27
Members of the board TitleAgeSince
Chairman 87 11-03-21
Director/Board Member 66 11-03-21
President 68 11-03-21
More insiders
Date Price Change Volume
24-03-28 5,220 +0.58% 10 600
24-03-28 5,190 -1.70% 44,800
24-03-27 5,280 +0.76% 77,100
24-03-26 5,240 +0.19% 29,400
24-03-25 5,230 -0.19% 50,500

Delayed Quote Japan Exchange, March 28, 2024 at 09:17 pm EDT

More quotes
Noevir Holdings Co., Ltd. is a Japan-based company engaged in the manufacture and sale of cosmetics, toiletries, pharmaceuticals and foods, as well as the purchase and sale of cosmetic products. The Company operates in three business segments. The Cosmetics segment is engaged in the manufacture and sale of cosmetics and toiletries, as well as the purchase and sale of cosmetic products. The Pharmaceuticals and Foods segment is engaged in the manufacture and sale of general drugs and foods. The Others segment is engaged in the purchase and sale of apparels, body fashion, aircrafts and vessels, as well as air transportation business.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
-
More Ratings
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
1
Last Close Price
5,190 JPY
Average target price
5,730 JPY
Spread / Average Target
+10.40%
Consensus
  1. Stock
  2. Equities
  3. Stock Noevir Holdings Co., Ltd. - Japan Exchange